175 related articles for article (PubMed ID: 17635127)
1. Cathepsin K in the bone microenvironment: link between obesity and prostate cancer?
Podgorski I; Linebaugh BE; Sloane BF
Biochem Soc Trans; 2007 Aug; 35(Pt 4):701-3. PubMed ID: 17635127
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin K mRNA and protein expression in prostate cancer progression.
Brubaker KD; Vessella RL; True LD; Thomas R; Corey E
J Bone Miner Res; 2003 Feb; 18(2):222-30. PubMed ID: 12568399
[TBL] [Abstract][Full Text] [Related]
3. When prostate cancer meets bone: control by wnts.
Emami KH; Corey E
Cancer Lett; 2007 Aug; 253(2):170-9. PubMed ID: 17462819
[TBL] [Abstract][Full Text] [Related]
4. Dynamic process of prostate cancer metastasis to bone.
Tantivejkul K; Kalikin LM; Pienta KJ
J Cell Biochem; 2004 Mar; 91(4):706-17. PubMed ID: 14991762
[TBL] [Abstract][Full Text] [Related]
5. A cathepsin K inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.
Le Gall C; Bellahcène A; Bonnelye E; Gasser JA; Castronovo V; Green J; Zimmermann J; Clézardin P
Cancer Res; 2007 Oct; 67(20):9894-902. PubMed ID: 17942921
[TBL] [Abstract][Full Text] [Related]
6. Circulating cathepsin K and cystatin C in patients with cancer related bone disease: clinical and therapeutic implications.
Tumminello FM; Flandina C; Crescimanno M; Leto G
Biomed Pharmacother; 2008 Feb; 62(2):130-5. PubMed ID: 17728092
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of bone metastasis in prostate cancer: clinical implications.
Msaouel P; Pissimissis N; Halapas A; Koutsilieris M
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):341-55. PubMed ID: 18471791
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
9. The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells.
Russell MR; Jamieson WL; Dolloff NG; Fatatis A
Oncogene; 2009 Jan; 28(3):412-21. PubMed ID: 18850002
[TBL] [Abstract][Full Text] [Related]
10. Bone directed therapies for prostate cancer.
Bradley DA; Hussain M; Dipaola RS; Kantoff P
J Urol; 2007 Sep; 178(3 Pt 2):S42-8. PubMed ID: 17644119
[TBL] [Abstract][Full Text] [Related]
11. Targeting bone metastasis in prostate cancer with endothelin receptor antagonists.
Carducci MA; Jimeno A
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6296s-6300s. PubMed ID: 17062717
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
[TBL] [Abstract][Full Text] [Related]
13. Bone metastases in prostate cancer: a targeted approach.
Storey JA; Torti FM
Curr Opin Oncol; 2007 May; 19(3):254-8. PubMed ID: 17414645
[TBL] [Abstract][Full Text] [Related]
14. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
Loberg RD; Gayed BA; Olson KB; Pienta KJ
J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin K inhibitors as treatment of bone metastasis.
Le Gall C; Bonnelye E; Clézardin P
Curr Opin Support Palliat Care; 2008 Sep; 2(3):218-22. PubMed ID: 18685424
[TBL] [Abstract][Full Text] [Related]
16. Bone and prostate cancer cell interactions in metastatic prostate cancer.
Vela I; Gregory L; Gardiner EM; Clements JA; Nicol DL
BJU Int; 2007 Apr; 99(4):735-42. PubMed ID: 17166237
[TBL] [Abstract][Full Text] [Related]
17. The role of tumor microenvironment in prostate cancer bone metastasis.
Morrissey C; Vessella RL
J Cell Biochem; 2007 Jul; 101(4):873-86. PubMed ID: 17387734
[TBL] [Abstract][Full Text] [Related]
18. The development and function of the skeleton and bone metastases.
Rodan GA
Cancer; 2003 Feb; 97(3 Suppl):726-32. PubMed ID: 12548569
[TBL] [Abstract][Full Text] [Related]
19. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
Ye L; Kynaston HG; Jiang WG
Int J Mol Med; 2007 Jul; 20(1):103-11. PubMed ID: 17549396
[TBL] [Abstract][Full Text] [Related]
20. Bone imaging in prostate cancer.
Dotan ZA
Nat Clin Pract Urol; 2008 Aug; 5(8):434-44. PubMed ID: 18682719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
